MyAverix Finance
F · Healthcare
Spyre Therapeutics, Inc. (3920)
Biotechnology
Spyre Therapeutics, Inc. (3920) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 3920
Spyre Therapeutics, Inc. (3920) — FAQ
What is 3920's P/E ratio?
The price-to-earnings (P/E) ratio for Spyre Therapeutics, Inc. (3920) is 18.00 (data as of 2026-03-24).
Does Spyre Therapeutics, Inc. pay a dividend?
Dividend yield is not available in the current snapshot for Spyre Therapeutics, Inc. (3920). Check the MyAverix Finance app for the latest dividend data.
What sector is Spyre Therapeutics, Inc. in?
Spyre Therapeutics, Inc. (3920) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 3920 listed on?
3920 is listed on F.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.